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Abstract
In the present study, the incidence and antimicrobial resistance patterns of the microorganisms that caused bloodstream infections
(BSIs) in a medical–surgical intensive care unit during the years 2005–2007 were determined. The mean BSI incidence density was 6.56
per 1000 patient-days. The incidence density increased linearly during the study period (from 3.57 to 9.60 per 1000 patient-days). Staph-
ylococcus aureus was most frequently isolated (47.3%), followed by Enterococcus spp. (10.8%) and Candida spp. (10.1%). There was a high
rate of resistance to several of the prescribed antimicrobials among the bacteria isolated from patients with BSIs.
Keywords: Bloodstream infection, incidence, aetiology, antimicrobial resistance, intensive care unit
Original Submission: 9 September 2008; Revised Submission: 31 January 2009; Accepted: 6 February 2009
Editor: D. Raoult
Article published online: 22 June 2009
Clin Microbiol Infect 2009; 15: 943–946
Corresponding author and reprint requests: I. Erdem, Namık
Kemal Universitesi, Tıp Fakultesi, Enfeksiyon Hastalıkları Anabilim
Dalı, Arastırma ve Uygulama Hastanesi, 59100 Tekirdag, Turkey
E-mail: ierdem@nku.edu.tr
Introduction
Bloodstream infections (BSIs) occur more frequently
in patients hospitalized in intensive care units (ICUs) than in
other units. It has been shown that these patients stay in
clinics longer than others. BSIs also cause an increase in hos-
pital mortality rates and excess cost. Early initiation of
appropriate antimicrobial treatment is critical in decreasing
morbidity and mortality among patients with BSI [1–3].
The frequency, epidemiology and microbiological proﬁle of
nosocomial BSIs varies among institutions and also among
ICUs within hospitals. Therefore it is important to know the
pathogens causing BSIs and their antimicrobial resistance pat-
terns to guide appropriate antimicrobial treatment. Based on
local surveillance data, each centre should make its own
therapatic choices [1,4]. The objective of this study was to
determine the incidence and the aetiology of BSIs, and the
antimicrobial resistance patterns of the BSI-causing micro-
organisms, in the medical–surgical ICU of Haydarpasa
Numune Hospital, Istanbul, Turkey.
Patients and Methods
Setting
This observational study was performed in the medical–surgi-
cal ICU of a teaching hospital with 750 beds in Istanbul, dur-
ing the years 2005–2007. The ICU, which had 12 beds in
2005, grew to have 21 beds and moved to a new location
within the hospital in 2006. The ICU had a patient-to-nurse
ratio of 3 : 1 during the daytime and 2 : 1 at night in 2005,
but in 2006–2007 this ratio was 4 : 1 during daytime and
3 : 1 at night.
Data collection
The patients hospitalized longer than 48 h in the ICU were
included in this study. The diagnosis of BSI was based on the
criteria of the Center for Disease Control (CDC) [5]. Iso-
lates were identiﬁed using standard methods [6]. Antimicro-
bial resistance patterns of isolated microorganisms were
determined using the disc diffusion agar method according to
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the recommendations of the Clinical Laboratory Standards
Institute (CLSI) [7]. The statistical analysis of the data was
done using the chi-square test or Fisher’s exact test when
expected values were small.
Deﬁnitions
BSI was deﬁned as the isolation of a pathogenic microorgan-
ism from at least one blood culture specimen. Organisms of
the skin ﬂora commonly associated with contamination were
required to be isolated from two separate blood culture
specimens. A poly-microbial BSI was deﬁned as the isolation
of more than one organism from blood culture specimens. A
BSI was classiﬁed as primary in the absence of an identiﬁed
source of infection or if it was catheter related. A BSI was
classiﬁed as secondary in the presence of an identiﬁed
source infected with the same microorganism at another
body site. Incidence density of BSIs was calculated per 1000
patient-days. The incidence density of catheter-associated
BSIs was calculated per 1000 catheter-days.
Results
In total, 2627 patients were admitted to the medical–surgical
ICU during the 3-year study period. The main admission
diagnoses were respiratory (20.36%) and neurological dis-
eases (19.03%) between the years 2005–2007; 121 (4.60%)
episodes of BSI among 113 patients were identiﬁed. The
majority of the episodes (116; 95.9%) were monomicrobial,
the rest (5, 4.1%) were polymicrobial; 83 (68.6%) episodes
were classiﬁed as primary BSI, 48 (57.8%) of which were vas-
cular catheter associated. Thirty-eight (31.4%) episodes were
classiﬁed as secondary BSI of which 30 (24.8%) were second-
ary to a lower respiratory tract infection, ﬁve (4.1%) second-
ary to a urinary tract infection and three (2.5%) secondary
to infection of other sites. The incidence densities of primary
and secondary BSI were 4.50 and 2.06 per 1000 patient-days,
respectively. The incidence density of catheter-associated BSI
was 2.92 per 1000 catheter-days. The mean incidence den-
sity of BSI was 6.56 per 1000 patient-days (range, 3.57–9.60
episodes). The incidence density of BSI increased during the
study period from 3.57 episodes in 2005 to 5.61 in 2006 and
to 9.6 per 1000 patient-care days in 2007; these results were
statistically highly signiﬁcant (p <0.0001) (Table l).
Among the BSI episodes, 83 (64.3%) were caused by
Gram-positive organisms, 25.6% by Gram-negative organisms
and 10.1% by fungi. The most fequently isolated microorgan-
isms of BSIs were Staphylococcus aureus (47.3%), enterococci
(10.8%) and Candida spp. (10.1%). Candida albicans (44.5%)
was the most frequently isolated species, followed by C. tropi-
calis (33.3%), C. glabrata (11.1%) and C. parapsilosis (11.1%).
The proportion of enterococcal species isolated from BSIs
increased from 5.5% in 2005 to 10.8% in 2007 (p = 0.4522).
The proportion of Candida spp. isolated from BSI increased
from 5.5% in 2005 to 10.1% in 2007 (p = 0.6799). However,
there was a decrease in the proportion of Gram-negative
bacteria isolated from BSI, from 38.8% in 2005 to 23.6% in
2007 (p = 0.2870). Acinetobacter spp. were the most fre-
quently isolated Gram-negative bacteria. The data are sum-
marized in Table 2.
In the present study, all isolates of S. aureus and coagu-
lase-negative staphylococci (CoNS) were resistant to methi-
cillin. All isolates were susceptible to vancomycin, teicoplanin
and linezolid. The rate of vancomycin resistance among
Enterococcus spp. was 50%. All seven of these resistant iso-
lates were Enterococcus faecium. Of 14 Enterococcus spp., only
four (28%) isolates were susceptible to ampicillin. The effec-
tive antibiotics against the Gram-negative bacteria were ami-
kacin, imipenem and cefoperazone-sulbactam. Among the
Gram-negative bacteria, the rates of resistance to various
antibiotics commonly used in the ICU were as follows: ami-
kacin 18%, imipenem 21%, cefoperazone-sulbactam 24%, cip-
roﬂoxacin 70%, ceftazidime 79%. Cefoperazon-sulbactam
showed high activity against Acinetobacter spp., whereas ami-
kacin showed high activity against Pseudomonas aeruginosa.
The rates of resistance to imipenem were 37% and 38% for
Acinetobacter spp. and P. aeruginosa, respectively. These
results are shown in Table 3 in detail.
TABLE 1. Accumulated incidence of bloodstream infections
2005 2006 2007 Total
Number of BSI cases 18 36 67 121
Rate per 100 patients 2.40 3.92 6.90 4.60
Patients days 5036 6407 6979 18 422
Rate per 1000 patient-days 3.57 5.61 9.60 6.56
BSI, bloodstream infections.
TABLE 2. The distrubition of pathogens isolated from
patients with BSIs
Microorganism
2005 2006 2007 Total
n % n % n % n %
Staphylococcus aureus 8 44.7 21 53.8 32 44.4 61 47.3
Coagulase-negative
staphylococci
1 5.5 3 7.7 4 5.5 8 6.2
Enterococcus spp. 1 5.5 3 7.7 10 14.0 14 10.8
Pseudomonas aeruginosa 3 16.8 1 2.6 4 5.5 8 6.2
Acinetobacter spp. 1 5.5 5 12.8 5 7.0 11 8.5
Escherichia coli 1 5.5 0 0.0 2 2.8 3 2.3
Klebsiella pneumoniae 1 5.5 2 5.1 2 2.8 5 3.9
Enterobacter spp. 1 5.5 1 2.6 4 5.5 6 4.7
Candida spp. 1 5.5 3 7.7 9 12.5 13 10.1
Total 18 100.0 39 100.0 72 100.0 129 100.0
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Discussion
Nosocomial BSIs are associated with a high morbidity and
mortality. Patients hospitalized in ICUs are at particulary high
risk of nosocomial BSIs because of their debilitated condition
as a result of underlying disease and frequent invasive diag-
nostic and therapeutic procedures [8,9]. Incidences of noso-
comial BSIs in ICU patients reported in the literature are
less than 5% [3,9]. The incidence density of BSIs in ICUs has
been reported to vary from 4.2 to 6.0 per 1000 patient-days
[3,10–12].
In this study, the incidence of BSIs was 4.60%. The mean
incidence density of nosocomial BSIs was 6.56. In 2007, there
was a signiﬁcant increase in the incidence of BSIs. This study
had not assessed the characteristics and risk factors of the
patients with BSI. The main diagnoses of the patients upon
admission to the ICU were similiar during the 3-year study
period. We know that an insufﬁcient number of nurses is an
important problem in the ICU of Haydarpasa Numune Hos-
pital which may explain why effective strategies to prevent
and control hospital infections are needed.
Organisms causing nosocomial BSIs vary depending upon
the location of patients within the institution [1]. In many
studies, the dominance of Gram-positive pathogens has
been documented. CoNS, S. aureus and enterococci were
the three most common causes of nosocomial BSIs in many
institutions [1,4,10,13,14]. There has been a decrease in rel-
ative importance of infections as a result of Gram-negative
bacteria over the past three decades [3,15]. Candida albicans
is still considered the most frequently isolated fungal agent
of BSI, but trends towards increasing numbers of non-albi-
cans Candida among bloodstream pathogens have been
reported [16].
In this study, the majority of ICU-acquired BSIs were as a
result of Gram-positive organisms. The most frequently iso-
lated microorganisms causing BSIs were S. aureus (47.3%),
enterococci (10.8%) and Candida spp. (10.1%).
Most of the fungi were C. albicans. There was an increase
in the proportion of enterococci and Candida species among
isolates from BSIs. This increase may be explained by exten-
sive use of antibiotics and indwelling devices in this unit.
Increasing antimicrobial resistance rates among microor-
ganisms isolated from BSIs are a signiﬁcant problem
worldwide. Methicillin-resistant S. aureus (MRSA), vancomy-
cin-resistant enterococci (VRE), extended-spectrum beta-lac-
tamase-producing Klebsiella spp., carbapenem-resistant
enterobactericeae, P. aeruginosa and Acinetobacter spp. were
seen more frequently in ICU patients than in non-ICU
patients in many countries [1,8,17–23]. Antimicrobial resis-
tance rates among pathogens isolated in ICUs in Turkey
were high [24–26]. In the present study, all staphylococcal
isolates were methicillin resistant and belonged to an ende-
mic strain (data not shown).
The rate of VRE was 50%. Vancomycin was used fre-
quently in this unit. There was an increase in the frequency
of VRE in 2007. Amikacin, imipenem and cefoperazone-
sulbactam were the most active compounds against
Gram-negative bacteria.
In conclusion, this study demonstrates a high rate of anti-
microbial resistance to several prescribed antibiotics among
the microorganisms isolated from patients with BSIs. During
the 3-year period, there was a tendency towards an increase
in frequency of BSIs and BSIs as a result of enterococci and
Candida spp. were more common in 2007. The insufﬁcient
antibiotic-prescribing practices, especially the unnecessary
use of broad-spectrum antibiotics together with the insufﬁ-
cient hospital infection prevention programme, are consid-
ered to be the cause of both a high antimicrobial resistance
rate and an increased incidence of BSI.
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TABLE 3. Antibiotic resistance rates among 33 Gram-negative pathogens isolated from BSIs
Pathogen
Antibiotic resistance rates
Ceftazidime Imipenem Ciproﬂoxacin
Cefoperazone-
sulbactam Amikacin
n % n % n % n % n %
Acinetobacter spp.
(n = 11)
10 91 4 37 8 73 0 0 5 45
Pseudomonas aeruginosa
(n = 8)
5 63 3 38 6 75 4 50 0 0
Enterobactericeae
(n = 14)
11 79 0 0 9 64 4 29 1 7
Total 26 79 7 21 23 70 8 24 6 18
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